Information Provided By:
Fly News Breaks for April 27, 2017
VAR
Apr 27, 2017 | 09:57 EDT
As previously reported, Barrington analyst Michael Petusky downgraded Varian Medical to Market Perform from Outperform as he believes the stock is approaching fair value after having risen by 16% since early January. The analyst thinks the stock will likely "trade sideways" despite the company's solid Q2 report and "reasonably good guidance," he tells investors.
News For VAR From the Last 2 Days
There are no results for your query VAR